Interferon-lambda serum levels in hepatitis C

Journal of Hepatology

Volumn 54, Issue 5, 2011, Pages 859-865

  Langhans, Bettina ^a   Kupfer, Bernd ^a   Braunschweiger, Ingrid ^a   Arndt, Simone ^a   Schulte, Wibke ^a   Nischalke, Hans Dieter ^a   Nattermann, Jacob ^a   Oldenburg, Johannes ^a   Sauerbruch, Tilman ^a   Spengler, Ulrich ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Dendritic cells (DCs); Hepatitis C virus (HCV); IFN lambdas (IL 29, IL 28A B); IL 28B rs12979860 T C polymorphism

Indexed keywords

GLYCOPROTEIN E2; INTERLEUKIN 28; INTERLEUKIN 28B; INTERLEUKIN 29; NONSTRUCTURAL PROTEIN 3; POLYINOSINIC POLYCYTIDYLIC ACID;

ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DNA POLYMORPHISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HUMAN CELL; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADULT; AGED; ANTIGENS, CD; CROSS-SECTIONAL STUDIES; DENDRITIC CELLS; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERLEUKINS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROGNOSIS; TOLL-LIKE RECEPTOR 2; VIRAL ENVELOPE PROTEINS; VIRAL LOAD; VIRAL NONSTRUCTURAL PROTEINS;

EID: 79954756911     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2010.08.020     Document Type: Article

References (42)

1. G.M. Lauer, and B.D. Walker Hepatitis C virus infection N Engl J Med 345 2001 41 52 (Pubitemid 32634271)
2. I. Pachiadakis, G. Pollara, B.M. Chain, and N.V. Naoumov Is hepatitis C virus infection of dendritic cells a mechanism facilitating viral persistence? Lancet Infect Dis 5 2005 296 304 (Pubitemid 40602249)
3. B. Rehermann Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence J Clin Invest 119 2009 1746 1964
4. R.S. Longman, A.H. Talal, I.M. Jacobson, M.L. Albert, and C.H. Rice Presence of functional dendritic cells in patients chronically infected with hepatitis C virus Blood 103 2004 1026 1029 (Pubitemid 38129566)
5. R.S. Longman, A.H. Talal, I.M. Jacobson, C.M. Rice, and M.L. Albert Normal functional capacity in circulating myeloid and plasmacytoid dendritic cells in patients with chronic hepatitis C JID 192 2005 497 502
6. D. Piccioli, S. Tavarini, S. Nuti, P. Colombatto, M. Brunetto, and F. Bonino Comparable functions of plasmacytoid and monocyte-derived dendritic cells in chronic hepatitis C patients and healthy donors Hepatology 42 2005 61 67 (Pubitemid 40038901)
7. E. Barnes, M. Salio, V. Cerundolo, L. Francesco, D. Pardoll, and P. Klenerman Monocyte derived dendritic cells retain their functional capacity in patients following infection with hepatitis C virus J Viral Hepat 15 2008 219 228 (Pubitemid 351143744)
8. C. Bain, A. Fatmi, F. Zoulim, J.P. Zaraki, C. Trepo, and G. Inchauspe Impaired allostimulatory function of dendritic cells in chronic hepatitis C Gastroenterology 120 2001 512 524 (Pubitemid 32147649)
9. S. Auffermann-Gretzinger, E.B. Keeffe, and S. Levy Impaired dendritic cell maturation in patients with chronic, but not resolved, hepatitis C virus infection Blood 97 2001 3171 3176
10. T. Kanto, M. Inoue, H. Miyatake, A. Sato, M. Sakakibara, and T. Yakushijin Reduced numbers and impaired ability of myeloid and plasmacytoid dendritic cells to polarize T helper cells in chronic hepatitis C virus infection J Infect Dis 190 2004 1919 1926 (Pubitemid 39564696)
11. A. Dolganiuc, S. Chang, K. Kodys, P. Mandrekar, G. Bakis, and M. Cormier Hepatitis C virus (HCV) core protein-induced, monocyte-mediated mechanisms of reduced IFN-alpha and plasmacytoid dendritic cell loss in chronic HCV infection J Immunol 177 2006 6758 6768 (Pubitemid 44715040)
12. G.R. Stark, I.M. Kerr, B.R. Williams, R.H. Silverman, and R.D. Schreiber How cells respond to interferons Annu Rev Biochem 67 1998 227 264 (Pubitemid 28411130)
13. S.V. Kotenko, G. Gallagher, V.V. Baurin, A. Lewis-Antes, M. Shen, and N.K. Shan IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex Nat Immunol 4 2003 69 77 (Pubitemid 36109115)
14. P. Sheppard, W. Kindsvogel, W. Xu, K. Henderson, S. Schlutsmeyer, and T.E. Whitmore IL-28, IL-29 and their class II cytokine receptor IL-28R Nat Immunol 4 2003 63 68 (Pubitemid 36104710)
15. S.S. Diebold, M. Montoya, H. Unger, L. Alexopoulou, P. Roy, and L.E. Haswell Viral infection switches non-plasmacytoid dendritic cells into high interferon producers Nature 424 2003 324 328 (Pubitemid 36899375)
16. G. Pollara, M. Jones, M.E. Handley, M. Rajpopat, A. Kwan, and R.S. Coffin Herpes simplex virus type-1-induced activation of myeloid dendritic cells: the roles of virus cell interaction and paracrine type I IFN secretion J Immunol 173 2004 4108 4119 (Pubitemid 39280776)
17. E.M. Coccia, M. Severa, E. Giacomini, D. Monneron, M.E. Remoli, and I. Julkunen Viral infection and Toll-like receptor agonists induce a differential expression of type I and lambda interferons in human plasmacytoid and monocyte-derived dendritic cells Eur J Immunol 34 2004 796 805 (Pubitemid 39255927)
18. K. Onoguchi, M. Yoneyama, A. Takemura, A. Akari, T. Taniguchi, and H. Namiki Viral infections activate types I and III interferon genes through a common mechanism J Biol Chem 282 2007 7576 7581 (Pubitemid 47093699)
19. N. Ank, M.B. Iversen, C. Bartholdy, P. Staeheli, R. Hartmann, and U.B. Jensen An important role for type III interferon (IFN-lambda/IL-28) in TLR-induced antiviral activity J Immunol 180 2008 2474 2585
20. P. Osterlund, V. Veckman, J. Sirén, K.M. Klucher, J. Hiscott, and S. Matikainen Gene expression and antiviral activity of alpha/beta interferons and interleukin-29 in virus-infected human myeloid dendritic cells J Virol 79 2005 9608 9617 (Pubitemid 41022304)
21. P.I. Osterlund, T.E. Pietilä, V. Veckman, S.C. Kotenko, and I. Julkunen IFN regulatory factor family members differentially regulate the expression of type III IFN (IFN-lambda) genes J Immunol 179 2007 3434 3442
22. S. Brand, F. Beigel, T. Olzak, K. Zitzmann, S.T. Eichhorst, and J.M. Otte IL-28A and IL-29 mediate antiproliferative and antiviral signals in intestinal epithelial cells and murine CMV infection increases colonic IL-28A expression Am J Physiol Gastrointest Liver Physiol 289 2005 G960 G968
23. H. Zhu, M. Butera, D.R. Nelson, and C. Liu Novel type I interferon IL-28A suppresses hepatitis C viral RNA replication Virol J 2 2005 80
24. M.D. Robek, B.S. Boyd, and F.V. Chisari Lambda interferon inhibits hepatitis B and C replication J Virol 79 2005 3851 3854 (Pubitemid 40327973)
25. S.H. Hong, O. Cho, K. Kim, H.J. Shin, S.V. Kotenko, and S. Park Effect of interferon-lambda on replication of hepatitis B virus in human hepatoma cells Virus Res 126 2007 245 249 (Pubitemid 46726717)
26. N.E. Pagliaccetti, R. Eduardo, S.H. Kleinstein, X.J. Mu, P. Bandi, and M.D. Robek Interleukin-29 functions cooperatively with interferon to induce antiviral gene expression and inhibit hepatitis C virus replication J Biol Chem 283 2008 300079 300089
27. V. Suppiah, M. Moldovan, G. Ahlenstiel, T. Berg, M. Weltman, and M.L. Abate IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy Nat Genet 41 2009 1100 1104
28. Y. Tanaka, N. Nishida, M. Sugiyama, M. Kurosaki, K. Matsuura, and N. Sakamoto Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C Nat Genet 41 2009 1105 1109
29. D.L. Thomas, C.L. Thio, M.P. Martin, Y. Qi, D. Ge, and C. O'Huigin Genetic variation in IL28B and spontaneous clearance of hepatitis C virus Nature 461 2009 798 801
30. D. Ge, J. Fellay, A.J. Thompson, J.S. Simon, K.V. Shianna, and T.J. Urban Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance Nature 461 2009 399 401
31. A. Rauch, Z. Kutalik, P. Descombes, T. Cai, J. Di Iulio, and T. Mueller Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study Gastroenterology 138 2010 1338 1345
32. S. Marukian, C.T. Jones, L. Andrus, M.J. Evans, K.D. Ritola, and E.D. Charles Cell culture-produced hepatitis C virus does not infect peripheral blood mononuclear cells Hepatology 48 2008 1843 1850
33. S.E. Doyle, H. Schreckhise, K. Khuu-Duong, K. Henderson, R. Rosler, and H. Storey Interleukin-29 uses a type 1 interferon-like program to promote antiviral responses in human hepatocytes Hepatology 44 2006 896 906 (Pubitemid 46489554)
34. C. Dellgren, H.H. Gad, O.J. Hamming, J. Melchjorsen, and R. Hartmann Human interferon-λ3 is a potent member of the type III interferon family Genes Immun 10 2009 125 131
35. M. Stoltz, C. Ahlm, A. Lundkvist, and J. Klingström Lambda interferon (IFN-lambda) in serum is decreased in hantavirus-infected patients, and in vitro established infection is insensitive to treatment with all IFNs and inhibits IFN-gamma-induced nitric oxide production J Virol 81 2007 8685 8691 (Pubitemid 47242842)
36. M. Shiina, and B. Rehermann Cell culture-produced hepatitis C virus impairs plasmacytoid dendritic cell function Hepatology 47 2008 385 395 (Pubitemid 351280706)
37. K.M. Spann, K.C. Tran, B. Chi, R.L. Rabin, and P.L. Collins Suppression of the induction of alpha, beta, and lambda interferons by the NS1 and NS2 proteins of human respiratory syncytial virus in human epithelial cells and macrophages J Virol 78 2005 6705 (Pubitemid 38715968)
38. S. Chang, A. Dolganiuc, and G. Szabo Toll-like receptors 1 and 6 are involved in TLR2-mediated macrophage activation by hepatitis C virus core and NS3 proteins J Leukoc Biol 82 2007 479 487 (Pubitemid 47367138)
39. S. Crotta, A. Stilla, A. Wack, A. D'Andrea, S. Nuti, and U. D'Oro Inhibition of natural killer cells through engagement of CD81 by the major hepatitis C virus envelope protein J Exp Med 195 2002 35 41 (Pubitemid 34074494)
40. C.T. Tseng, and G.R. Klimpel Binding of the hepatitis C virus envelope protein E2 to CD81 inhibits natural killer cell functions J Exp Med 195 2002 43 49 (Pubitemid 34074495)
41. W.J. Jordan, J. Eskdale, S. Srinivas, V. Pekarek, D. Kelner, and M. Rodia Human interferon lambda-1 (IFN-lambda1/IL-29) modulates the Th1/Th2 response Genes Immun 8 2007 254 261 (Pubitemid 46679436)
42. S. Srinivas, J. Dai, J. Eskdale, G.E. Gallagher, N.J. Megjuforac, and G. Gallagher Interferon lambda 1 (interleukin-29) preferentially down-regulates interleukin-13 over other T helper type 2 cytokine responses in vitro Immunology 125 2008 492 502